Search hospitals > Ohio > Sylvania
ProMedica Flower Hospital
Claim this profileSylvania, Ohio 43560
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
222 reported clinical trials
12 medical researchers
Summary
ProMedica Flower Hospital is a medical facility located in Sylvania, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. ProMedica Flower Hospital is involved with conducting 222 clinical trials across 374 conditions. There are 12 research doctors associated with this hospital, such as Jamie L. Dargart, Abhijit B. Saste, Adam C. Walter, and Jeffrey H. Muler.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
Jamie L. DargartProMedica Toledo Hospital/Russell J Ebeid Children's Hospital6 years of reported clinical research
Expert in Tumors
Expert in Cancer
53 reported clinical trials
108 drugs studied
Abhijit B. SasteProMedica Flower Hospital5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
12 reported clinical trials
28 drugs studied
Adam C. WalterProMedica Flower Hospital5 years of reported clinical research
Studies Cancer
Studies Adenocarcinoma
9 reported clinical trials
24 drugs studied
Jeffrey H. MulerProMedica Flower Hospital1 year of reported clinical research
Studies Cancer
Studies Transitional Cell Carcinoma
10 reported clinical trials
27 drugs studied
Clinical Trials running at ProMedica Flower Hospital
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Prostate Cancer
Cancer
Colorectal Cancer
Ovarian Tumors
Squamous Cell Carcinoma
Germ Cell Tumors
Ovarian Carcinoma
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at ProMedica Flower Hospital?
ProMedica Flower Hospital is a medical facility located in Sylvania, Ohio. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Recurrence, Adenocarcinoma and other specialties. ProMedica Flower Hospital is involved with conducting 222 clinical trials across 374 conditions. There are 12 research doctors associated with this hospital, such as Jamie L. Dargart, Abhijit B. Saste, Adam C. Walter, and Jeffrey H. Muler.